Significant controversy surrounds current recommendations for breast cancer screening. This has resulted in wide variation among national organizations in breast cancer screening guidelines. With the expanding field of breast imaging techniques, risk assessment and genetic testing, it has become clear that the recommendations for breast cancer screening need to be individualized in order to maximize the benefit and minimize harms of screening.
Copyright 2020 by the Missouri State Medical Association.
Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1. Ont Health Technol Assess Ser. 2007. PMID: 23074501 Free PMC article.
A systematic assessment of benefits and risks to guide breast cancer screening decisions.JAMA. 2014 Apr 2;311(13):1327-35. doi: 10.1001/jama.2014.1398. JAMA. 2014. PMID: 24691608 Review.
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.J Natl Cancer Inst. 2017 Jan 27;109(5). doi: 10.1093/jnci/djw290. Print 2017 Jan. J Natl Cancer Inst. 2017. PMID: 28130475 Review.
The UK breast screening program - what you need to know.Climacteric. 2017 Aug;20(4):313-320. doi: 10.1080/13697137.2017.1342619. Epub 2017 Jun 29. Climacteric. 2017. PMID: 28661704 Review.
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.Ann Ital Chir. 2019;90:1-2. Ann Ital Chir. 2019. PMID: 30872561